Le traitement antituberculeux présomptif est-il licite dans la pleurésie lymphocytaire exsudative inexpliquée au Sénégal ?
M. Sané(Hôpital Principal de Dakar), J. Margery, B. Chevalier(Jackson Laboratory), K. Bâ-Fall, J.-M. Debonne, D. Mounguengui(Hôpital Principal de Dakar), Nicolas Lefèbvre(Hôpital Civil, Strasbourg), P. Camara(Hôpital Principal de Dakar), A. Bonnichon(Hôpital d'instruction des Armées Percy), A. Niang(Hôpital d'instruction des Armées Percy), P. Saliou-Mbaye(Hôpital Principal de Dakar)
Cited by 3
Related Papers
Noninvasive Diagnosis of Actionable Mutations by Deep Sequencing of Circulating Free DNA in Lung Cancer from Never-Smokers: A Proof-of-Concept Study from BioCAST/IFCT-1002
|Clinical Cancer Research|2014|213
Cloning and variation of ground state intestinal stem cells
|Nature|2015|200
Clinical characteristics and risk factors associated with severe COVID-19: prospective analysis of 1,045 hospitalised cases in North-Eastern France, March 2020
|Eurosurveillance|2020|129
Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France
|EBioMedicine|2020|113
Risk factors for death among tuberculosis cases: analysis of European surveillance data
|European Respiratory Journal|2008|99